Optimizing the management of patients with chronic migraine and neck pain: a prospective randomized trial with long-term follow-up
Abstract
Most patients with chronic migraine (CM) have musculoskeletal neck pain, which maintains the chronic course of migraine and complicates treatment. Cognitive behavioral therapy (CBT) is promising in the complex treatment of patients with CM and cervicalgia. However, few randomized trials have been conducted to evaluate the effectiveness of CBT in CM.The aim of the study was to evaluate the effectiveness of an multidisciplinary program including CBT in the treatment of patients with CM and neck pain.Material and methods. The study included 120 patients with CM and neck pain (41 men and 79 women), average age 35.7 ± 9.2 years. All patients underwent a clinical interview, neurological examination and testing using clinical and psychological methods. Patients were randomized into two groups: group 1 received standard treatment and CBT, group 2 — only standard treatment. All patients were assessed for clinical and psychological indicators before treatment and at 3, 6, 12 and 24 months follow-up.Results. At 3 months follow-up, statistically significant (p < 0.05) improvement was observed in group 1: decrease in headache frequency, frequency and doses of taking painkillers (PK), neck pain intensity by the Visual Analogue Scale (VAS), the Total pericranial pain score, in the Migraine Disability Assessment (MIDAS), in the Neck Disability Index (NDI), in the Pain catastrophizing scale, the State-Trait Anxiety Inventory, the Center for Epidemiologic Studies Depression Scale. At 6, 12…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 120 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.